346 filings
Page 14 of 18
4
drzx2 rjos
16 Mar 21
Change in insider ownership
7:37pm
4
5ho1v75w8t
16 Mar 21
Kymera Therapeutics / Elena Ridloff ownership change
5:22pm
3
papedjxfvq4 dr
16 Mar 21
Kymera Therapeutics / Elena Ridloff ownership change
5:18pm
8-K
3aw5 hi1z
16 Mar 21
Departure of Directors or Certain Officers
4:15pm
4
lc4zauumq
15 Mar 21
Kymera Therapeutics / Jared Gollob ownership change
9:12pm
4
el0mvy4ligilvx2wpq
15 Mar 21
Kymera Therapeutics / Bruce N. Jacobs ownership change
9:08pm
S-8
4v4m 195qz3
11 Mar 21
Registration of securities for employees
7:29am
10-K
kslpi5
11 Mar 21
Annual report
7:19am
8-K
abvd1jx
11 Mar 21
Kymera Therapeutics Announces Fourth Quarter and Full Year 2020 Financial
7:09am
SEC STAFF
t2o5ut7w a3xzaq
11 Mar 21
SEC staff action: Order
12:00am
4
hojchbj2v8zk8alh
8 Mar 21
Kymera Therapeutics / Bruce N. Jacobs ownership change
8:01pm
4
7zmm 3oqcqs7
5 Mar 21
Kymera Therapeutics / Bruce N. Jacobs ownership change
5:26pm
4
9ne01h
3 Mar 21
Kymera Therapeutics / Jared Gollob ownership change
4:57pm
4
uml91zhrg2s sy
3 Mar 21
Kymera Therapeutics / Nello Mainolfi ownership change
4:54pm
4
rldiz
3 Mar 21
Kymera Therapeutics / Richard Chesworth ownership change
4:52pm
4
g043a785
3 Mar 21
Kymera Therapeutics / Bruce N. Jacobs ownership change
4:27pm
8-K
pr5aveit40y hix87xk5
2 Mar 21
KT-474 is the first IRAK4 degrader, and first heterobifunctional small molecule protein degrader outside of oncology, to enter clinical development
7:15am
4
ptnc8l
24 Feb 21
Kymera Therapeutics / Jared Gollob ownership change
6:44pm
4
5nuqndhmuy8
22 Feb 21
Change in insider ownership
4:58pm
4
gdil 6ca7kd8eis
19 Feb 21
Kymera Therapeutics / Jared Gollob ownership change
7:27pm